Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,001,722
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
2,352,300
-
Shares change
-
+671,399
-
Total reported value, excl. options
-
$19,044,605
-
Value change
-
+$5,865,507
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$9.14
Significant Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q2 2023
19 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,352,300 shares
of 86,001,722 outstanding shares and own 2.7% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1,351,275 shares), FMR LLC (491,746 shares), VANGUARD GROUP INC (205,154 shares), RENAISSANCE TECHNOLOGIES LLC (98,300 shares), BlackRock Inc. (78,831 shares), GEODE CAPITAL MANAGEMENT, LLC (51,964 shares), ACADIAN ASSET MANAGEMENT LLC (21,463 shares), Virtu Financial LLC (20,993 shares), STATE STREET CORP (13,719 shares), and MORGAN STANLEY (8,995 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.